Breaking News
May 24, 2018 - Tau mutations may serve as novel risk factor for cancer
May 24, 2018 - Sun Pharma Announces FDA Approval of Yonsa (abiraterone acetate) to Treat Metastatic Castration-Resistant Prostate Cancer
May 24, 2018 - Nurse dead in Congo as Ebola vaccination campaign starts
May 24, 2018 - Unique imaging technique identifies biomarkers of cellular damage done by diabetic retinopathy
May 24, 2018 - Study identifies key food allergy policies that parents want in schools to improve safety of kids
May 24, 2018 - Formaldehyde risk found to be higher in e-cigarettes than originally thought
May 24, 2018 - NIH commences first-in-human trial evaluating experimental treatment for Ebola
May 24, 2018 - Study finds no link between surveillance intensity and detection of recurrence or survival in CRC patients
May 24, 2018 - FDA Alert: Oral Over-the-Counter Benzocaine Products: Drug Safety Communication
May 24, 2018 - Fiber-fermenting bacteria improve health of type 2 diabetes patients
May 24, 2018 - Higher exposure to carbon monoxide in utero increases risk of poor lung function in infants
May 24, 2018 - Neurologists identify new type of vertigo
May 24, 2018 - Scientists identify new inherited neurodevelopmental disease
May 24, 2018 - New family support program improves patient-centered care and lowers hospitalization costs
May 24, 2018 - Researchers take important step toward finding protein biomarkers during cancer surgery
May 24, 2018 - Deadly form of black lung disease found to be increasing among U.S. coal miners
May 24, 2018 - Robust Immune Responses for Herpes Zoster Subunit Vaccine
May 24, 2018 - Optical Coherence Tomography | Texas Heart Institute
May 24, 2018 - Type 2 diabetes slowly rising in Auckland kids – Pacific and Māori have highest rates
May 24, 2018 - Study explores brain chemistry of alcohol exposure in people with family history of AUD
May 24, 2018 - Study shows AVATS procedure as safe, effective alternative for patients deemed ‘inoperable’
May 24, 2018 - Comparative Analysis of a Complex Monoclonal Antibody
May 24, 2018 - Penn investigators discover source of immune molecule involved in nasal polyps, asthma
May 24, 2018 - Berries and Grapes May Keep You Breathin’ Easy
May 24, 2018 - Access and utilization of dental services for Medicaid children 2013-2015
May 23, 2018 - New research raises concern about rate of postpartum hemorrhage
May 23, 2018 - Researchers create new modeling framework that takes a zoonotic perspective on Ebola
May 23, 2018 - Study compares bacteria in humans to the laboratory
May 23, 2018 - Frequent sauna bathing reduces risk of stroke
May 23, 2018 - Landmark trial to test implantable defibrillator in diabetic patients with history of heart attack
May 23, 2018 - Vitamin C consumption may reduce harm to baby’s lungs due to smoking during pregnancy
May 23, 2018 - Researchers complete genomic map of chronic lymphocytic leukemia
May 23, 2018 - Medical students take to the streets to learn about real world problems at the root of poor health
May 23, 2018 - New efforts to curb high blood pressure in Asia
May 23, 2018 - Malaria-causing parasite seeks refuge inside the liver to replicate and survive
May 23, 2018 - Slower rates of stimulation may be more effective in brain therapy, suggests research
May 23, 2018 - Study finds connection between one partner’s BMI and other spouse’s risk of developing diabetes
May 23, 2018 - Mapping the Genes Responsible for Pluripotency
May 23, 2018 - FDA Alert: Homeopathic Teething Drops, Nausea Drops, Intestinal Colic Drops, Stomach Calm, Expectorant Cough Syrup, Silver-Zinc Throat Spray, and Argentum Elixir by MBI Distributing: Recall
May 23, 2018 - Genetic fixer-uppers may predict bladder cancer prognosis
May 23, 2018 - Investigational technology could increase donor organ supply for lung transplants
May 23, 2018 - Prediabetic patients with OSA could lower their resting heart rates by using CPAP
May 23, 2018 - Schizophrenics’ blood samples feature genetic material from more types of microorganisms
May 23, 2018 - Subtle hearing deficits can change the brains of young people
May 23, 2018 - New study shows increased rates of hospitalization for suicide among youths
May 23, 2018 - Proportion of Drug-Intoxicated Organ Donors on the Rise in U.S.
May 23, 2018 - Using virtual biopsies to improve melanoma detection
May 23, 2018 - Compassion meditation training may increase brain’s resilience to suffering of other people
May 23, 2018 - New AAD PSA uses social media imagery to highlight tanning hazards
May 23, 2018 - Frequent MRSA surveillance could contain infection in newborns, study finds
May 23, 2018 - Medicaid expansion linked to reduction in ICU utilization
May 23, 2018 - Proteins moderating nicotine dependence may help fat cells burn energy
May 23, 2018 - Researchers identify mechanisms that regulate mammary gland development
May 23, 2018 - ‘Low-Alcohol’ Booze Labels May Backfire
May 23, 2018 - Social isolation could increase risk of death, hospitalizations for heart failure patients
May 23, 2018 - New research shows that children with autism are able to create imaginary friends
May 23, 2018 - New technology could make prosthetic use more intuitive and reliable
May 23, 2018 - HU researchers explore how simulated microgravity affects gene expression, muscle cell differentiation
May 23, 2018 - Researchers develop injectable bandage to stop fatal blood loss, activate wound healing
May 23, 2018 - Exercising for 4-5 days per week is needed to keep the heart young
May 23, 2018 - Porvair Sciences offers wide range of reagent reservoirs for use with automated liquid handling systems
May 23, 2018 - New study unravels secrets of HIV’s persistence
May 23, 2018 - IDF launches initiative to improve health services for displaced people with diabetes
May 23, 2018 - Maintaining healthy weight between early adulthood and middle age could help avoid diabetes
May 23, 2018 - DNA vaccine shows promise for colorectal cancer
May 23, 2018 - Abnormal brain connections seen in preschoolers with autism
May 23, 2018 - Study finds increase in number of calls to US Poison Control Centers about ADHD medication exposures
May 23, 2018 - Yoghurt before a meal packed with health benefits
May 23, 2018 - New tool predicts the lifetime risk of Alzheimer’s
May 23, 2018 - Scientists reveal mechanisms that may help preterm infants extend nephron development window
May 23, 2018 - Unnecessary antibiotic use for asthma exacerbations linked to increased hospital stays, costs
May 23, 2018 - Quitting cigarettes linked to better lung health than long-term light smoking
May 23, 2018 - Researchers shed light on how androgen deprivation therapy increases risk for cardiovascular mortality
May 23, 2018 - Ingesting blue dye tablet during colonoscopy aids in detecting difficult-to-see polyps
May 23, 2018 - Patients with low-back pain benefit from early physical therapy
May 23, 2018 - Researchers discover link between tuberculosis and Parkinson’s disease
May 23, 2018 - FDA Approves Doptelet (avatrombopag) for Chronic Liver Disease Patients with Thrombocytopenia who are Undergoing a Medical Procedure
May 23, 2018 - Is knee pain linked to depression?
May 23, 2018 - Research team uncovers new information that more accurately explains formation of tumors
May 23, 2018 - Brain stimulation shows promise in treating obesity by reducing food cravings
D.C. Week: FDA Okays Single-Pill Tx for HIV

D.C. Week: FDA Okays Single-Pill Tx for HIV

image_pdfDownload PDFimage_print

WASHINGTON — The FDA approved a new two-drug combo for certain HIV patients, as well as the first epinephrine auto-injector for infants.

FDA Gives Nod to Two-Drug HIV Combo

For some people with HIV, the long-established three-drug treatment paradigm has been upset, with FDA approval of a new single-pill regimen that contains only two medications.

But the combination of dolutegravir (Tivicay), and rilpivirine (Edurant) — to be marketed as Juluca — isn’t for everyone, the FDA cautioned. Only patients whose infection has been suppressed for at least 6 months on a standard three-drug regimen — and who have neither a history of treatment failure nor any HIV mutations associated with resistance to either dolutegravir or rilpivirine — will be eligible to use the new combination.

“Limiting the number of drugs in any HIV treatment regimen can help reduce toxicity for patients,” Debra Birnkrant, MD, of the FDA Center for Drug Evaluation and Research, said in a statement announcing the approval.

Opioids: FDA Issues New Guidance

The FDA on Tuesday issued a final guidance document to help companies develop generic versions of approved abuse-deterrent opioids.

FDA Commissioner Scott Gottlieb, MD, said in a statement that the guidance was “one piece of the FDA’s ongoing work aimed at finding solutions to combat the opioid crisis.”

Although the agency would ultimately like to reduce the number of people addicted to opioids by decreasing exposure to them, “we also must take steps to help those with acute and chronic pain who need access to medicines, including opioids, get access to improved alternatives,” said Gottlieb. “Until we’re able to find new non-opioid forms of pain management for those who need treatment for pain, it’s critical that we also continue to promote the development of opioids that are harder to manipulate and abuse, and take steps to encourage their use over opioids that don’t offer any form of abuse deterrence.”

The FDA has so far approved 10 abuse-deterrent opioid formulations, but uptake has been slow, he noted. “The reason for their more limited use is likely multifold. We know there can be a learning curve that comes with new technologies. Some prescribers may not be aware of the existence of these drugs, or may be uncertain of when to prescribe the abuse-deterrent versions.”

Less Waste Means Better Healthcare, Expert Advises

Eliminating waste in the healthcare system to curb healthcare costs is truly possible, a health policy expert advised.

“The United States has spent $3.4 trillion dollars on care delivery, and I’m suggesting that half of that is recoverable waste, potentially,” said Brent James, MD, senior fellow at the Institute for Healthcare Improvement, and former Chief Quality Officer of Intermountain Health, in a talk at the American Enterprise Institute on Monday.

James, a contributor to the “To Err is Human: Building a Safer Health System” from the National Academies of Sciences, Engineering, and Medicine, argued that “any competent care delivery team” needs to focus on eliminating waste in the healthcare system. He said the rewards of such a strategy are “dramatically higher” than more traditional revenue enhancement strategies, such as increasing the volume of laboratory tests and scans.

FDA OKs Epinephrine Auto-Injector for Small Children

The FDA has approved the first epinephrine auto-injector specifically designed for infants and small children weighing 16.5 to 33 lbs, Kaléo, the device’s manufacturer, announced Monday.

The AUVI-Q 0.1 mg device is “specifically designed for the treatment of life-threatening allergic reactions, including anaphylaxis, in infants and small children weighing 16.5 to 33 lbs (7.5 to 15 kg) who are at risk for or have a history of serious allergic reactions,” the company said in a press release.

“Until now, healthcare practitioners and caregivers to infants and small children have not had an epinephrine auto-injector with an appropriate dose of epinephrine available to them, potentially causing some delay in the administration of epinephrine in a life-threatening allergic emergency,” said Vivian Hernandez-Trujillo, MD, a pediatric allergist at Nicklaus Children’s Hospital in Miami, in the release.

“Having an epinephrine auto-injector with a needle length and dose specifically designed for infants and small children should help alleviate concerns around hitting the bone or injecting too much epinephrine.”

Next Week

The Coalition to Transform Advanced Care (C-TAC) will host the National Summit on Advanced Illness Care from Monday to Wednesday.

On Tuesday, the House Committee on Oversight and Government Reform will explore strategies for fighting the opioid crisis at a field hearing in Baltimore.

On Wednesday, the Senate Help, Education, Labor, and Pensions (HELP) Committee will discuss the nomination of Alex Azar to lead the U.S. Department of Health and Human Services.

On Thursday, the Senate HELP Committee will hear from government and medical experts on the front lines of the opioid epidemic. And a subcommittee for the House Committee on Energy & Commerce will examine the impact of the 21st Century Cures Act.

Also, Health Affairs will host a discussion on workplace satisfaction among physicians.

On Thursday and Friday, the FDA’s Blood Products Advisory Committee will discuss “bacterial risk control strategies for blood collection establishments and transfusion services.”

On Friday, the Alliance for Health Policy will discuss the future of Medicare payment.

2017-11-25T11:00:00-0500

Tagged with:

About author

Related Articles